← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1999Last known activity
Jul 15, 2017
Timeline
1980s
- Jan 1, 1988
French National Agency for Research on AIDS and Viral Hepatitis— Founded
Drugs by trial phase (87 distinct, 122 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (32 own, 0 via acquisition)
Phase 2 (38 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Carcinoma
- Carcinoma, Hepatocellular
- Castleman Disease
- Cocaine-Related Disorders
- Coinfection
- Communicable Diseases
- Cryoglobulinemia
- Depressive Disorder
- End Stage Liver Disease
- Fever
- Fibrosis
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hepatitis, Viral, Human
- Herpes Genitalis
- HIV-Associated Lipodystrophy Syndrome
- HIV Infections
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Infections
- Influenza, Human
- Insulin Resistance
- Leukoencephalopathies
- Leukoencephalopathy, Progressive Multifocal
- Lipodystrophy
- Liver Cirrhosis
- Liver Cirrhosis, Experimental
- Liver Diseases
- Liver Failure
- Lymphoma
- Lymphoma, AIDS-Related
- Lymphoma, Non-Hodgkin
- Meningitis
- Meningitis, Cryptococcal
- Osteoporosis
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Substance-Related Disorders
- Syndrome
- Tobacco Use Disorder
- Tuberculosis
- Tuberculosis, Pulmonary
- Ulcer
- Vasculitis
- Viremia
- Virus Diseases
- Xeroderma Pigmentosum
- Yellow Fever
Recent trials (50)
- NCT03090269Lead sponsorPhase 2Jul 15, 2017
- NCT03113123Lead sponsorN/AMay 3, 2017
- NCT02937779Lead sponsorPhase 4Apr 1, 2017
- NCT02972450Lead sponsorPhase 2Feb 1, 2017
- NCT02987530Lead sponsorPhase 3Jan 1, 2017
- NCT02777229Lead sponsorPhase 3Jul 1, 2016
- NCT02738502Lead sponsorPhase 2Jun 1, 2016
- NCT02150993Lead sponsorPhase 2/Phase 3Jan 26, 2016
- NCT02647632Lead sponsorPhase 2Jan 1, 2016
- NCT02405013Lead sponsorPhase 2Oct 1, 2015
- NCT02527096Lead sponsorPhase 2Sep 1, 2015
- NCT02273765Lead sponsorPhase 3Sep 1, 2015
- NCT02624453Lead sponsorN/AJul 1, 2015
- NCT02384967Lead sponsorPhase 2Mar 1, 2015
- NCT02212379Lead sponsorPhase 2Jan 1, 2015
Details
- Founded
- Paris, FR Jan 1, 1988
- Last known activity
- Jul 15, 2017